Management of Tuberculosis Patient in Hong Kong - PowerPoint PPT Presentation

About This Presentation
Title:

Management of Tuberculosis Patient in Hong Kong

Description:

Medical conditions of patients at the time of. developing TB (notified in August 1999) (Total ... Repeat chest radiograph. Sputum examination. Health education: ... – PowerPoint PPT presentation

Number of Views:74
Avg rating:3.0/5.0
Slides: 38
Provided by: tamche
Category:

less

Transcript and Presenter's Notes

Title: Management of Tuberculosis Patient in Hong Kong


1
Management ofTuberculosis Patientin Hong Kong
  • (10 December 2000)

2
(No Transcript)
3
(No Transcript)
4
Medical conditions of patients at the time
ofdeveloping TB (notified in August 1999) (Total
no. 594)
  • One or more medical conditions 155 (26.09)
  • Two medical conditions 16 (2.69)
  • Three medical conditions 2 (0.34)
  • Total number of cases analysed 594
  • (Apart from this no reply received for 28 cases)

5
Medical conditions of patients at the time
ofdeveloping TB (notified in August 1999) (Total
no. 594)
  • Medical conditions Number
  • Diabetes mellitus 72 12.12
  • On steroid 8 1.35
  • Chronic renal failure 18 3
  • On cytotoxic drug 1 0.17
  • Leukaemia/ lymphoma 4 0.67
  • Malignancy 27 4.55
  • Alcoholism 10 1.68
  • Drug addiction 6 1.01
  • Pneumoconiosis 9 1.52
  • Others 20 3.37

6


7
SOURCES OF CARE FOR PATIENTS WITH TUBERCULOSIS
IN HONG KONG
PATIENT WITH TUBERCULOSIS
Hospital Authority Accident and Emergency
Departments
Department of Health General out- patient clinics
Department of Health TB Chest Service 18 chest
clinics 7,000 new patients each year
PRIMARY LEVEL
Private Practitioner
Hospital Authority Chest Hospitals 5
hospitals 800 beds 7,000 in-patient episodes
Hospital Authority Specialist Out-patient Clinics
Private Hospitals
Hospital Authority General Hospital
SECONDARY LEVEL
8
Classical symptoms suspicious of TB
  • persistent cough for over 3 to 4 weeks
  • blood in sputum
  • weight loss
  • persistent fever
  • night sweating

9
Particular points to note in the history
  • previous history of TB - previous ST pattern
  • coexisting medical illnesses
  • occupational history - e.g., health care worker,
    silicosis
  • contact history - e.g., ST of source case
  • smoking status
  • previous BCG (especially for child)

10
Physical examination
  • often yields negative findings
  • general condition
  • cervical LN
  • pleural effusion
  • unilateral wheeze (endobronchial involvement)
  • help in differential diagnosis e.g., finger
    clubbing favour CA lung

11
Diagnosis
  • Chest X-ray relatively simple, sensitive, but
    less specific
  • apical lesion high positive predictive value
  • If sputum smear negative, usually needs serial
    film to assess activity of pneumonic shadow ?
    trial of antibiotics (ddx from other community
    acquired pneumonia)
  • Sputum examination for AFB (smear and culture)
  • on 2 to 3 consecutive mornings
  • identification and sensitivity tests should be
    done for positive culture isolates
  • Further tests may be required for difficult
    cases
  • CT scan, bronchoscopy, needle lung biopsy
  • tuberculin test (usually limited use)

12
Before starting anti-TB drugs
  • Note contraindication to use of anti-TB drugs
  • liver disease, renal disease, visual problem,
    hearing problem, drug allergy, concomitant
    medication
  • Young females counselled on pregnancy-related
    issues
  • interaction with oral contraceptives
  • avoidance of pregnancy during anti-TB treatment
  • Pretreatment LFT, RFT, HIV antibody (with
    consent), screening test for vision

13
Before starting anti-TB drugs (Contd)
  • Health education nature of disease, healthy
    lifestyle, drug-adherence, possible side effects
    of drugs (discoloration of body fluid)
  • supplemented with educational materials
  • self-reporting of side effects
  • Good rapport with patient

14
Public Health Functions
  • Notification of TB
  • Contacts
  • examination of close contacts
  • stone-in-the-pond principle
  • health education maintenance of good bodily
    health and early awareness of suspicious symptoms
  • Health education on patients personal hygiene

15
TB Notification System in Hong Kong
  • (1) Prevention of the Spread of Infectious
  • Diseases Regulations (under Quarantine and
  • Prevention of Disease Ordinance)(Cap.141)
  • (TB is a statutory notifiable disease
    since 1939)
  • (Report to Department of Health)
  • (2) Occupational Safety and Health Ordinance
  • (E.g., health-care workers)
  • (Prescribed period 6 months)
  • (Report to Labour Department)

16
  • Notification form
  • available from
  • - any chest clinics
  • DH homepage
  • Completed form sent back to
  • Wanchai Chest Clinic
  • Fax 28346627
  • Tel 25726024

17
TB Notification
  • Aims
  • Surveillance
  • Contact tracing and examination
  • Identification of clusters

18
  • Under-notification
  • A common problem
  • The importance of the need to notify TB cases
    should be recognised.
  • Guidance Notes for notification of TB
  • Leung CC, Tam CM. Guidance notes for notification
    of tuberculosis. Public Health Epidemiology
    Bulletin 19998(4)36-9.

19
Source of TB Notification
20
Infectiousness of the TB patient
  • Sputum smear a general guide to the
    infectiouness
  • also severe cough, cavitatory disease
  • To reduce risk of infection to others
  • prompt initiation of treatment (infectivity
    reduced significantly after 2 weeks of treatment
    in which rifampicin is included)
  • health education
  • personal hygiene measures
  • good indoor ventilation
  • screening of close contacts
  • sick leave assessed on a case-to-case basis
    (teachers, staff of elderly homes, etc.)

21
TUBERCULOSISCHEMOTHERAPY
  • DIRECTLY OBSERVED TREATMENT,
  • SHORT COURSE
  • to stop it at the source

22
do s
TB
TB
s op
23
DOT (directly observed treatment)
  • Strongly recommended by WHO, crucial for
    treatment success

24
  • Short course service programme (6 months)
  • 2H3R3Z3E3 / 4H3R3
  • H isoniazid R rifampicin
  • Z pyrazinamide E ethambutol
  • S streptomycin
  • Drugs preferably taken in a single dose each
    time and not in split doses
  • Combined drug preparations e.g., rifater,
    rifinah
  • useful alternatives, but have to be given daily
  • can avoid monotherapy
  • but do not allow flexible dosage adjustment

25
Treatment of tuberculosis
  • The Tuberculosis Control Coordinating Committee
    of the Hong Kong Department of Health and the
    Tuberculosis Subcommittee of the Coordinating
    Committee in Internal Medicine of the Hospital
    Authority, Hong Kong. Chemotherapy of
    tuberculosis in Hong Kong a consensus statement.
  • Hong Kong Med J 19984315-20

26
During anti-TB treatment
  • Initial phase follow up at least monthly (in
    chest clinic, while under DOT)
  • to reinforce patient education
  • watch out for adverse drug reactions
  • routine blood tests usually not necessary unless
    clinical features suspicious of hepatitis,
    underlying liver disease, etc.
  • CXR at 2nd or 3rd month to assess progress
  • Sputum
  • If pretreatment sputum positive, recheck at 2nd
    month to assess conversion to negativity
  • If still positive at 2nd month, recheck at 3rd
    month

27
During anti-TB treatment (Contd)
  • Treatment defaulters being traced by health
    nurses
  • Identify the underlying reasons for default, and
    try to solve the problem as far as possible
  • Incentives/ enablers
  • Tracing back of treatment defaulters IMPORTANT
    for treatment success and public health control
    of TB.
  • Defaulters are a potential persistent source of
    infection in the community.

28
At the end of six months treatment
  • Assessment
  • Repeat chest radiograph
  • Sputum examination
  • Health education
  • Maintenance of a healthy lifestyle, awareness of
    suspicious symptoms

29
Complicating issues
  • Examples of complicating issues
  • Extensive disease
  • Poor general condition
  • Diagnostic dilemma
  • Treatment failure due to non-adherence
  • Drug resistance
  • Concurrent medical diseases
  • Drug reactions
  • Consult when necessary, hospitalisation may be
    required

30
Tuberculosis- Indications for hospital admission
  • 1. Complications of pulmonary tuberculosis, e.g.,
    pleural effusion, pneumothorax, etc.
  • 2. Complications of treatment, e.g., severe
    reactions like drug intolerance, hypersensitivity
    reactions, hepatitis, etc.
  • 3. Concomitant diseases, e.g., uncontrolled DM.
  • 4. Psychosocial problems, e.g., alcoholics, drug
    addicts, previous defaulters.
  • 5. Difficulty in attending clinics for DOT, e.g.,
    elderly, hemiplegic, living in remote areas, etc.
  • 6. Extrapulmonary TB for special investigation

31
Some points for caution
  • Addition phenomenon to be avoided
  • Not to add a single drug to a failing regimen
  • Desensitisation
  • May be required for drug-induced
    hypersensitivity, but be careful not to induce
    drug-resistance
  • Ethambutol to be avoided under age 6 unless
    necessary
  • Higher incidence of side effects of drugs in
    elderly

32
IMPORTANT
  • Drug adherence is most important and is
    vulnerable because
  • Long duration of treatment required
  • Disappearance of symptoms before treatment
    completion
  • Bulk of tablets mistake, GI upset and other
    side effects
  • Stigma of TB cannot accept the fact of being
    diagnosed as having TB
  • Health belief e.g., use of herbal or alternative
    medicine
  • DOT is strongly recommended
  • Prevent failure, relapse, drug-resistance, spread
    of the disease, long-term sequelae of destroyed
    lung

33
TUBERCULOSIS
  • Reasons for failure of chemotherapy
  • Non-compliance
  • Drug resistant tuberculosis
  • Drug toxicity
  • Failure of drug to reach site of action
  • Immunosuppressed

34
Conclusion
  • Management of TB can be simple, but can go
    wrongly easily, which can result in serious
    consequences
  • Complicating issues may arise from time to time
  • Caution required, consult when necessary
  • Management
  • Clinical Public Health measures Good
    communication

35
Components of DOTS
  • 1. Government commitment to sustained TB control.
  • 2. Sputum smear microscopy to detect infectious
    cases.
  • 3. A standardized, short-course anti-TB treatment
    regimen of six to eight months, with direct
    observation of treatment for at least the initial
    two months.
  • 4. A regular, uninterrupted supply of quality
    anti-TB drugs.
  • 5. A MONITORING AND REPORTING SYSTEM to evaluate
    treatment outcomes for each patient diagnosed and
    the performance of the TB control programme as a
    whole.

36
Future activities
  • Programme Forms (to be filled in for all TB
    patients starting from January 2001)
  • Baseline characteristics of TB patient
  • Clinical features and results of investigations
  • Treatment outcomes at various time points up to 2
    year from DOS (date of starting treatment)
  • The collaboration of both the PUBLIC AND PRIVATE
    SECTOR in the evaluation process is very
    important and very much appreciated.

37
The collaboration of public and private sector in
the control of tuberculosis is very
important.THANK YOU!
Write a Comment
User Comments (0)
About PowerShow.com